Matthew Robertson
Overview
Explore the profile of Matthew Robertson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
493
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cantave M, Chen A, Carrubba A, Robertson M
Cureus
. 2025 Feb;
17(1):e77664.
PMID: 39974235
Metastatic lesions to the ovary from melanoma are very rare. There have been several published case reports over the years documenting melanoma metastasizing to the adnexa. Ovarian metastases may either...
2.
Divakaran S, Harms H, Robertson M, Merugumala S, Park M, Kijewski M, et al.
J Nucl Cardiol
. 2025 Jan;
:102143.
PMID: 39889951
Background: The pathophysiology of symptoms and reduced exercise capacity from peripheral artery disease (PAD) remains unclear. Additionally, there is limited information on blood flow and skeletal muscle energetics after walking...
3.
Divakaran S, Randhawa V, Tahir U, Robertson M, Waheed A, Perillo A, et al.
ESC Heart Fail
. 2024 Dec;
PMID: 39631426
Aims: Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients...
4.
Clerc O, Datar Y, Cuddy S, Bianchi G, Taylor A, Benz D, et al.
JACC Cardiovasc Imaging
. 2024 Jul;
17(8):911-922.
PMID: 39001731
Background: Positron emission tomography/computed tomography (PET/CT) with F-florbetapir, a novel amyloid-targeting radiotracer, can quantify left ventricular (LV) amyloid burden in systemic light-chain (AL) amyloidosis. However, its prognostic value is not...
5.
Liebowitz S, Robertson M
Front Health Serv Manage
. 2024 May;
40(4):14-18.
PMID: 38781507
Since the early 2000s, artificial intelligence (AI) has raised concerns regarding its use in healthcare to manage vast amounts of patient data, ensure proper handling, and maintain robust security measures....
6.
Finn A, Nugent J, Qi S, Robertson M, Bobel M, Brunsvold M
J Surg Educ
. 2024 Apr;
81(6):786-793.
PMID: 38658312
Objective: Didactic education in General Surgery (GS) residency typically follows a nationally standardized curriculum; however, instructional format varies by institution. In recent years, GS residents at our institution expressed discontentment...
7.
Clerc O, Datar Y, Cuddy S, Bianchi G, Taylor A, Benz D, et al.
medRxiv
. 2023 Sep;
PMID: 37745589
Background: Myocardial immunoglobulin light-chain (AL) amyloid deposits trigger heart failure, cardiomyocyte stretch and myocardial injury, leading to adverse cardiac outcomes. Positron emission tomography/computed tomography (PET/CT) with F-florbetapir, a novel amyloid-targeting...
8.
Clerc O, Cuddy S, Robertson M, Vijayakumar S, Canseco Neri J, Chemburkar V, et al.
JACC Cardiovasc Imaging
. 2023 Sep;
16(11):1419-1432.
PMID: 37676210
Background: Cardiac amyloid quantification could advance early diagnosis of amyloid cardiomyopathy (CMP) and treatment monitoring. However, current imaging tools are based on indirect measurements. I-evuzamitide is a novel pan-amyloid radiotracer...
9.
Said J, Iriarte C, Talia J, Leung B, Virgen C, Robertson M, et al.
Clin Exp Dermatol
. 2023 Apr;
48(9):1077-1080.
PMID: 37119266
No abstract available.
10.
Goff J, Hina M, Malik N, McLardy H, Reilly F, Robertson M, et al.
J Pers Med
. 2023 Mar;
13(3).
PMID: 36983682
Background: A significant amount of evidence suggests that Opioid-Free Anaesthesia (OFA) may provide better outcomes for patients undergoing surgery, sparing patients who are particularly vulnerable to adverse side effects of...